Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$40.6M
+55.6% from 2023
Prescriptions
3,028
$13,421.41 per claim
Patients
402
285 prescribers
Total spending, 2024
$40.6M
$101,094.58 per patient
Medicare prescription drug plans paid $40.6M for Reblozyl in 2024, for 3,028 prescriptions and refills to 402 patients (up 55.6% from 2023). The average cost per claim was $13,421.41.
New York had the highest Medicare cost for Reblozyl in 2024: $11.7M for 822 claims, followed by California ($7.5M).
Norland Ng, hematology-oncology in New York, NY, had the highest Medicare cost for Reblozyl in 2024: 77 claims costing $915K.
Reblozyl is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as Celgene/BMS.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Norland Ng New York, NY | Hematology-Oncology | 77 | Under 11 | $915K |
| Tsz Isabel Wong New York, NY | Nurse Practitioner | 41 | Under 11 | $825K |
| Kirtan N Koticha |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 156 | 1,455 | 175 | $19.9M |
| 2023 | 217 | 1,882 | 256 | $26.1M |
| 2024 | 285 | 3,028 | 402 | $40.6M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 53 |
| Under 11 |
| $809K |
| Bertrand Y Tuan San Francisco, CA | Hematology-Oncology | 53 | Under 11 | $808K |
| Eric M Cheung Lakewood, CA | Hematology-Oncology | 45 | Under 11 | $770K |
| Jen Chin Wang Long Beach, NY | Internal Medicine | 61 | Under 11 | $740K |
| Manuel F Gonzalez Sumter, SC | Hematology-Oncology | 38 | Under 11 | $739K |
| Sanjeev Jain East Patchogue, NY | Hematology-Oncology | 32 | Under 11 | $683K |
| Seth A Benkel New City, NY | Hematology-Oncology | 44 | Under 11 | $659K |
| Elena Rampe Teaneck, NJ | Nurse Practitioner | 28 | Under 11 | $613K |
| William Cheung New York, NY | Internal Medicine | 52 | Under 11 | $612K |
| Susannah P Friemel Davenport, IA | Internal Medicine | 41 | Under 11 | $593K |
| Li-Teh Wu Elmhurst, NY | Medical Oncology | 38 | Under 11 | $537K |
| Yong Tang Hagerstown, MD | Hematology-Oncology | 37 | Under 11 | $513K |
| Javier Ruiz New Windsor, NY | Hematology-Oncology | 51 | Under 11 | $512K |
| Kai Zu La Mesa, CA | Hematology-Oncology | 34 | Under 11 | $480K |
| Gregory L Ortega Orange City, FL | Hematology-Oncology | 23 | Under 11 | $433K |
| Henry Vuong Lake Success, NY | Medical Oncology | 17 | Under 11 | $408K |
| James C Lasker Vero Beach, FL | Hematology-Oncology | 17 | Under 11 | $397K |
| Vaseem S Akhtar Okeechobee, FL | Medical Oncology | 40 | Under 11 | $371K |
| Adriana Guigova Port Jefferson Station, NY | Hematology-Oncology | 11 | Under 11 | $357K |
| Bilal Ahmed Prince Frederick, MD | Hematology-Oncology | 27 | Under 11 | $355K |
| Sanaullah Khalid Youngstown, OH | Hematology-Oncology | 17 | Under 11 | $351K |
| Girish S Amin Brick, NJ | Hematology-Oncology | 17 | Under 11 | $327K |
| Martin B Langford Glendale, AZ | Hematology-Oncology | 13 | Under 11 | $320K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Celgene/BMS BMY | 3,028 | $40.6M |